Progress towards a public chemogenomic set for protein kinases and a call for contributions
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference63 articles.
1. The protein kinase complement of the human genome;G Manning;Science,2002
2. FDA-approved small-molecule kinase inhibitors;P Wu;Trends in Pharmacological Sciences,2015
3. Targeting cancer with kinase inhibitors;S Gross;The Journal of Clinical Investigation,2015
4. Ten things you should know about protein kinases: IUPHAR Review 14;D Fabbro;British Journal of Pharmacology,2015
5. A historical overview of protein kinases and their targeted small molecule inhibitors;R Roskoski Jr.;Pharmacol Res,2015
Cited by 134 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Chemical coverage of human biological pathways;Drug Discovery Today;2024-10
2. Lessons learned during the journey of data: from experiment to model for predicting kinase affinity, selectivity, polypharmacology, and resistance;2024-09-10
3. Kinase Drug Discovery: Impact of Open Science and Artificial Intelligence;Molecular Pharmaceutics;2024-09-06
4. A Unified Conditional Diffusion Framework for Dual Protein Targets-Based Bioactive Molecule Generation;IEEE Transactions on Artificial Intelligence;2024-09
5. Identification of kinase inhibitors as potential host-directed therapies for intracellular bacteria;Scientific Reports;2024-07-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3